TELA — TELA Bio, Inc.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1561921 ·
Last close
$0.76
Market Cap
$34.44M
52W High
$1.50
52W Low
$0.50
ADV30
141,786
Next earnings
2026-11-10
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 18,959,000 12,308,000 -7,290,000 -9,302,000 49,494,000 22,664,000 74,070,000
Jun 2026 19,291,000 13,943,000 -9,283,000 -11,262,000 59,738,000 30,424,000 75,604,000
Mar 2026 19,059,000 12,520,000 -10,526,000 -12,273,000 69,891,000 39,541,000 75,092,000
Dec 2025 20,869,000 13,755,000 -6,648,000 -9,041,000 81,418,000 50,845,000 75,105,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-34,113,000
Investing CF
$1,638,000
Financing CF
$25,478,000
CapEx
$-276,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.74
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-430,398,000
Inventory
$11,609,000
Receivables
$9,273,000
ST Investments
—
EBIT TTM
$-33,645,000
Pretax Income TTM
$-41,510,000
Interest Exp TTM
$7,865,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$78,178,000
EBITDA
$-32,725,000
Free Cash Flow
$-16,964,500
Enterprise Value
$70,693,864
Total Cash
$22,664,000
Total Debt
$56,299,000
Shares Out
45,188,230
Trailing EPS
$-0.74
Book Value
$-0.54
ROE
-616.6%
ROA
-38.0%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 80,275,000 -33,755,000 -38,831,000 81,418,000 75,105,000 6,313,000 -28,219,000
Dec 2024 69,300,000 -41,695,000 -37,841,000 86,570,000 58,112,000 28,458,000 -41,595,000
Dec 2023 58,453,000 -44,075,000 -46,664,000 78,048,000 59,167,000 18,881,000 -40,857,000
Dec 2022 41,418,000 -39,007,000 -44,296,000 67,855,000 53,550,000 14,305,000 -40,748,000

TTM Snapshot

Revenues TTM
$79,908,000
NetIncome TTM
$-41,179,000
OpCashFlow TTM
—
Assets (Latest)
$59,738,000
Forward EPS
$-0.47

Peers — same industry

TickerNameMarket CapLastDaily %
IDXG INTERPACE BIOSCIENCES, INC. $33.24M $6.00 —
ADGM Adagio Medical Holdings, Inc. $36.65M $1.65 —
MYO MYOMO, INC. $36.85M $0.92 —
NXGL NEXGEL, INC. $37.04M $3.80 —
SRTS Sensus Healthcare, Inc. $37.20M $2.26 —

News headlines (Yahoo Finance, 1h cache)

TELA Bio Inc (TELA) (Q3 2026) Earnings Call Highlights: Cost Cuts, Leora Clearance and a Reset ...
2026-11-11 11:05 · Yahoo
TELA Bio (TELA) Q3 2026 Earnings Call Transcript
2026-11-11 03:44 · Yahoo
TELA Bio, Inc. Q3 2026 Earnings Call Summary
2026-11-11 03:27 · Yahoo
TELA Bio, Inc. (TELA) Reports Q3 Loss, Beats Revenue Estimates
2026-11-10 21:10 · Yahoo
TELA Bio Reports Third Quarter 2026 Financial Results
2026-11-10 21:00 · Yahoo
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-11-06 21:05 · Yahoo
TELA Bio to Announce Third Quarter 2026 Financial Results
2026-10-27 20:05 · Yahoo
TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue Reinforcement
2026-10-05 12:00 · Yahoo
TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative
2026-08-31 11:00 · Yahoo
TELA Bio (TELA) Q2 2026 Earnings Call Transcript
2026-08-19 13:01 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.